CSL Seqirus: A Pillar of Pandemic Preparedness with Fifth BARDA Award for Avian Influenza

CSL Seqirus: A Pillar of Pandemic Preparedness with Fifth BARDA Award for Avian Influenza CSL Seqirus, a leading global biotechnology company, has once again demonstrated its commitment to pandemic preparedness by securing its fifth award from the Biomedical Advanced Research and Development Authority (BARDA). This latest contract, valued at $121.4 million, is aimed at bolstering […]